Zenibell Snail Intensive

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Zenibell Snail Intensive
Generic name: GLYCERIN
Manufacturer: MISOCOS
Product type: HUMAN OTC DRUG
SPL set ID: 97747267-26f1-d06f-e053-2a95a90ab087
SPL ID: 1c78ff0d-e858-db4f-e063-6294a90ad1f4
Version: 2
Effective date: 2024-07-04
Source export date: 2026-09-28
Source partition: 1
Source file: https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/9c7783846d422acb0c9e59457606951c785a7d28cc631c8cc4839d0dc7c55f39/drug-label-0001-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:12:45

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 9 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		Zenibell Snail Intensive	openfda.brand_name
generic name		GLYCERIN	openfda.generic_name
manufacturer name		MISOCOS	openfda.manufacturer_name
ndc	package	73466-0001-1	openfda.package_ndc
ndc	product	73466-0001	openfda.product_ndc
ndc11	package	73466000101	derived:openfda.package_ndc
spl id		1c78ff0d-e858-db4f-e063-6294a90ad1f4	id
spl set id		97747267-26f1-d06f-e053-2a95a90ab087	set_id
unii		PDC6A3C0OX	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

■ if following abnormal symptoms occurs after use , stop use and consult with a skin specialist red specks, swelling, itching ■ don’t use on the part where there is injury, eczema, or dermatitis Keep out of reach of children ■ if swallowed, get medical help or contact a person control center immediately

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.